Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03814902 · ClinicalTrials.gov registry record · NA

A Pilot Study to Characterize the Household Impact of Locating Devices for Children With ASD Who Wander

A NA study of Autism Spectrum Disorder and Wandering Behavior, sponsored by Northwell Health.

Completed
Registry status
NA
Development phase
31
Enrollment target
1
Study location

NCT03814902 is a NA study of Autism Spectrum Disorder and Wandering Behavior that has completed, run by Northwell Health. The registered enrollment target is 31 participants, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03814902, a NA study of Autism Spectrum Disorder and Wandering Behavior, has completed, sponsored by Northwell Health.

COMPLETED
Registry status
NA
Development phase
31 participants
Enrollment target
1
Study location

Study Summary

This pilot study will obtain preliminary data about the impact of wearable electronic tracking devices (ETDs) as an intervention for children with autism spectrum disorders (ASD) who wander. The feasibility of all study procedures and the acceptability of the intervention will be evaluated.

Interventions

  • DEVICE Electronic Tracking Device

Study Locations (1)

New York

  • Cohen Children's Medical Center of New York - New Hyde Park

Trial Details

FieldValue
Enrollment Target 31 participants
Start Date 2019-01-15
Est. Completion 2019-11-11
Phase NA

Sponsor

Northwell Health

370 total trials

What the Registry Record Tells You About NCT03814902

The ClinicalTrials.gov registry entry for NCT03814902 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (77% lower). The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 1 intervention - of which Electronic Tracking Device is the first listed.

NCT03814902 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT03814902 about?

NCT03814902 is a clinical study titled "A Pilot Study to Characterize the Household Impact of Locating Devices for Children With ASD Who Wander". This pilot study will obtain preliminary data about the impact of wearable electronic tracking devices (ETDs) as an intervention for children with autism spectrum disorders (ASD) who wander. The feasibility of all study procedures and the acceptability of the intervention will be evaluated.

What is the current status of trial NCT03814902?

This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2019-01-15. Estimated completion is 2019-11-11.

What conditions does trial NCT03814902 study?

This clinical trial studies the following conditions: Autism Spectrum Disorder, Wandering Behavior.

What interventions are being tested in trial NCT03814902?

The interventions under investigation include: Electronic Tracking Device (DEVICE).

Who is sponsoring clinical trial NCT03814902?

This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03814902 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Autism Spectrum Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.